These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8436563)

  • 21. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.
    Nishida M; Kamimura T; Okada N; Matsumoto Y; Mine Y; Murakawa T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1979 Dec; 32(12):1319-27. PubMed ID: 317284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
    Klesel N; Isert D; Limbert M; Markus A; Seibert G; Schrinner E
    J Antibiot (Tokyo); 1990 Jan; 43(1):100-6. PubMed ID: 2407707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
    Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
    Cheng AF; Ling TK; Lam AW; Fung KS; Wise R
    J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P; Ryan DM; Sowa MA; Watts CM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
    Asahi Y; Miyazaki S; Yamaguchi K
    Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.
    Iwahi T; Okonogi K; Yamazaki T; Shiki S; Kondo M; Miyake A; Imada A
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1358-66. PubMed ID: 1510428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.
    Iizawa Y; Okonogi K; Hayashi R; Iwahi T; Yamazaki T; Imada A
    Antimicrob Agents Chemother; 1993 Jan; 37(1):100-5. PubMed ID: 8431004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
    Ueda Y; Kanazawa K; Eguchi K; Takemoto K; Eriguchi Y; Sunagawa M
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
    Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
    Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
    Climo MW; Markowitz SM; Williams DS; Hale-Cooper CG; Archer GL
    J Antimicrob Chemother; 1997 Jul; 40(1):59-66. PubMed ID: 9249205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo antibacterial activity of FK482, a new orally active cephalosporin.
    Mine Y; Yokota Y; Wakai Y; Kamimura T; Tawara S; Shibayama F; Kikuchi H; Kuwahara S
    J Antibiot (Tokyo); 1988 Dec; 41(12):1888-95. PubMed ID: 3209480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo antibacterial activity of FK041, a new orally active cephalosporin.
    Tawara S; Hatano K; Wakai Y; Matsumoto S; Watanabe Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):660-5. PubMed ID: 10513846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal pharmacokinetics of FK037, a novel parenteral broad-spectrum cephalosporin.
    Sakamoto H; Hatano K; Higashi Y; Mine Y; Nakamoto S; Tawara S; Kamimura T; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):120-30. PubMed ID: 8436544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2010)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Apr; 68(2):85-104. PubMed ID: 26182813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2008)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Feb; 68(1):19-36. PubMed ID: 25980051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H; Takeda H; Kawai S; Watanabe T; Okazaki M; Shimada K; Nakano K; Yokouchi H; Ikemoto H; Mori T; Igari J; Oguri T; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Kudo K; Kobayashi N; Tanaka T; Sumitomo M; Matsushima T; Oka M; Niki Y; Suga M; Tosaka M; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Nasu M; Hiramatsu K; Oikawa S
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.